Autoimmunity Reviews

Article	Citations
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	309
Editorial Board	189
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	153
Susac syndrome: A scoping review	148
Endometriosis and autoimmunity	118
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	112
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	97
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	96
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	88
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	85
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	84
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	78
“Fibromyalgia syndrome” related to Essure devices	78
Editorial Board	77
Editorial Board	77
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	76
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives	76
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	74
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	71
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	70
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	70
Can anticoagulation be withdrawn in APS patients after aPL negativization?	65
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis	63
STING-inflammasome axis in autoimmune diseases and inflammation-related disease	61
Psychiatric manifestations of autoimmune encephalitis	60

The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	57
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	54
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	54
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	52
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	52
Editorial Board	52
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	51
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	50
Seronegative autoimmune diseases: A challenging diagnosis	48
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	48
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	46
Autoimmune pre-disease	45
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	45
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	45
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	45
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	45
Autoimmunity in vitiligo: Therapeutic implications and opportunities	44
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	44
Editorial Board	43
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	43
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	43
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	42
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	41
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	41
A descriptive study of IgG4-related disease in children and young adults	40
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	39
SpA plus IBD or IBD plus SpA: Does commutative property apply?	39
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	39
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	39
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	38
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	38
Editorial Board	38
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	37
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	37
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	37
Adipose failure through adipocyte overload and autoimmunity	37
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives	36
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	35
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	35
Chronic inflammation in Long COVID relationship to autoimmune diseases	35
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	34
Development of an algorithm for IgG4-related disease management	33
Tumor necrosis factor-α inhibitor-related autoimmune disorders	33
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	32
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	32
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	32
Editorial Board	31
Fibromyalgia: Are we using the biopsychosocial model?	31
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	30
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	30

Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	30
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	29
Editorial Board	29
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	29
The role of mitochondrial dysfunction in kidney injury and disease	29
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	29
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	28
Mucous membrane pemphigoid	28
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	28
Editorial Board	28
Twenty shades of the mosaic of autoimmunity	28
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	27
Anti-rods/rings autoantibodies in a patient with pancreatic injury	27
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	27
Are IF-ANA the guiding light for SLE classification in the real-world setting?	27
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	27
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	27
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	27
Editorial Board	27
Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis	26
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	26
Reply letter to letter to the editor	26
Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review	26
Alarmins in autoimmune diseases	26
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	26
Neuroimaging in thyroid eye disease: A systematic review	25
Editorial Board	25
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	25
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	25
Cutting edge confusion about cut-off settings in autoimmune diagnostics	25
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	25
Salivary gland involvement in ANCA-associated vasculitis	24
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	24
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	24
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	24
IL-33 in Spondyloarthritis, the missing key	24
Is it time for treat-to-target in antiphospholipid syndrome?	24
Diagnostic approach in giant cell arteritis	24
In Memoriam: Pierre Youinou	24
Ferritinophagy in inflammatory and autoimmune diseases: Mechanistic insights and therapeutic potentials	23
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	23
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	23
Inflammatory muscle involvement in systemic vasculitis: A systematic review	22
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	22
From inflammation to renal fibrosis: A one-way road in autoimmunity?	22
Extending the discussion: Cannabis based therapies in inflammatory bowel disease a letter to the editor	22
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	22
JAK inhibitors and systemic sclerosis: A systematic review of the literature	22
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	22
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	22
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	22
Persistent aortic inflammation in patients with giant cell arteritis	21
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	21
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	21
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	21
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	21
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	21
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	21
Editorial Board	21
Serum calprotectin is a marker of disease activity in Giant cell arteritis	21
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	20
Rapid radiographic progression in rheumatoid arthritis: Definition, prediction and treatment	20
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	20
Editorial Board	20
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	20
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	20
Editorial Board	19
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	19
Don't mix apples and oranges. Reply to Azoulay et al.	19
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	19
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	19
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	19
Insights into new-onset autoimmune diseases after COVID-19 vaccination	18
Intermittent fasting: A promising dietary intervention for autoimmune diseases	18
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	18
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	18
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview	18
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	18
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	18
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	18

Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	18
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	18
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	17
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	17
Emerging roles of mechanically activated ion channels in autoimmune disease	17
Prevention of rheumatoid arthritis using a familial predictive medicine approach	17
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	17
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	17
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	17
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	17
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	17
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	17
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	17
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	17